Studies have confirmed that testosterone mediates the relationship between HGB levels and bone loss (57), and low testosterone levels are thought to be associated with anemia (low HGB levels) and reduced BMD in men (58, 59), so In patients with T2DM, the HGB-BMD correlation is more pronounced in older men. This evidence concerns the gene CYGB and anemia (phenotype).